Genetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• Rasopathies are a group of rare neurodevelopmental disorders.
• These disorders are caused by germline mutations activating the Ras/mitogen-activated protein kinase (MAPK) pathway.
• Understanding the specific contribution of downstream MAPK signaling to Rasopathy phenotypes is crucial.

Purpose of the Study:

• To investigate the role of downstream MAPK signaling in Rasopathy pathogenesis.
• To model the recently described MAPK1-related Rasopathy (MRR) using a gain-of-function mutation in the Mapk1 gene.
• To determine which Rasopathy sequelae result from hyperactivation of terminal MAP kinases.

Main Methods:

• Engineered mice with a gain-of-function mutation in the Mapk1 gene (encoding ERK2).
• Phenotypic analysis of Mapk1 mutant mice, including physical, cognitive, and neurological assessments.
• Comparison of phenotypes with existing Rasopathy models, such as neurofibromatosis type 1 (NF1).

Main Results:

• Mapk1 mutant mice successfully modeled key human MRR phenotypes: small stature, facial dysmorphism, and impaired cognition.
• These mice recapitulated Rasopathy phenotypes linked to upstream Ras activation, including oligodendrocyte lineage defects, astrogliosis, memory deficits, and sensory hypersensitivity.
• Findings highlight the critical role of ERK2 (encoded by Mapk1) in Rasopathy pathophysiology.

Conclusions:

• Downstream MAPK signaling, specifically via ERK2, plays a significant role in the neurocognitive aspects of Rasopathies.
• The Mapk1 mutant mouse model provides valuable insights into MRR and other Rasopathy syndromes.
• Targeting downstream MAPK pathways may offer therapeutic strategies for Rasopathy-associated neurocognitive deficits.